Drug Interaction Report
4 potential interactions and/or warnings found for the following 2 drugs:
- idelalisib
- Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid)
Interactions between your drugs
tetanus toxoid idelalisib
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), idelalisib
If you are currently being treated or have recently been treated with idelalisib, you should let your doctor know before receiving tetanus toxoid. Depending on the dose and length of time you have been on idelalisib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of idelalisib therapy. If you have recently been vaccinated with tetanus toxoid, your doctor may choose to postpone treatment with idelalisib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
diphtheria toxoid idelalisib
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), idelalisib
If you are currently being treated or have recently been treated with idelalisib, you should let your doctor know before receiving diphtheria toxoid. Depending on the dose and length of time you have been on idelalisib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of idelalisib therapy. If you have recently been vaccinated with diphtheria toxoid, your doctor may choose to postpone treatment with idelalisib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
pertussis, whole cell idelalisib
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), idelalisib
If you are currently being treated or have recently been treated with idelalisib, you should let your doctor know before receiving pertussis, whole cell. Depending on the dose and length of time you have been on idelalisib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of idelalisib therapy. If you have recently been vaccinated with pertussis, whole cell, your doctor may choose to postpone treatment with idelalisib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
haemophilus b conjugate (HbOC) vaccine idelalisib
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), idelalisib
If you are currently being treated or have recently been treated with idelalisib, you should let your doctor know before receiving haemophilus b conjugate (HbOC) vaccine. Depending on the dose and length of time you have been on idelalisib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of idelalisib therapy. If you have recently been vaccinated with haemophilus b conjugate (HbOC) vaccine, your doctor may choose to postpone treatment with idelalisib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.